Shuttle Pharmaceuticals Holdings, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 5.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 24.92M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.